Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZR75B | HR+ | Luminal | Docetaxel | TUBB | TUBB | 10 | uM | 9997.002 | 0.7077 | 0.4029 | 0.9751 | |
| ZR75B | HR+ | Luminal | Docetaxel | TUBB | TUBB | 0.4 | uM | 9997.002 | 0.7170 | 0.4219 | 0.9751 | |
| ZR75B | HR+ | Luminal | Docetaxel | TUBB | TUBB | 0.00064 | uM | 9997.002 | 1.0196 | 1.0402 | 0.9751 | |
| ZR75B | HR+ | Luminal | Docetaxel | TUBB | TUBB | 0.016 | uM | 9997.002 | 0.8289 | 0.6499 | 0.9751 | |
| ZR75B | HR+ | Luminal | Etoposide | TOP2 | TOP | 0.000853 | uM | 7555.074 | 0.9094 | 0.8893 | 1.6682 | |
| ZR75B | HR+ | Luminal | Etoposide | TOP2 | TOP | 2.67 | uM | 7555.074 | 0.5616 | 0.4153 | 1.6682 | |
| ZR75B | HR+ | Luminal | Etoposide | TOP2 | TOP | 0.00427 | uM | 7555.074 | 0.9631 | 0.9554 | 1.6682 |